Search results
Showing 601 to 615 of 2579 results for methods
Evidence-based recommendations on fenfluramine (Fintepla) for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over.
In development Reference number: GID-TAG509 Expected publication date: 28 September 2016
Awaiting development Reference number: GID-TA11659 Expected publication date: 13 May 2027
In development Reference number: GID-MT526 Expected publication date: TBC
In development Reference number: GID-TA11584 Expected publication date: 08 December 2027
In development Reference number: GID-TA10748 Expected publication date: TBC
In development Reference number: GID-TA11422 Expected publication date: TBC
This document is one of a series describing the processes and methods that NICE uses to carry out technology appraisals. It focuses on the technology appraisal processes
Duvelisib for treating relapsed or refractory peripheral T-cell lymphoma [ID5076]
Awaiting development Reference number: GID-TA10961 Expected publication date: TBC
Vosoritide for treating achondroplasia in children and young people under 18 years [ID3807]
Awaiting development Reference number: GID-TA10700 Expected publication date: TBC
We are listening to your views on this Technology appraisal guidance. Comments close 20 February 2026.
In development Reference number: GID-TA11694 Expected publication date: TBC
In development Reference number: GID-TA11130 Expected publication date: TBC
We are listening to your views on this Technology appraisal guidance. Comments close 18 February 2026.
In development Reference number: GID-TA11674 Expected publication date: 07 May 2026